Home
OriCiro Genomics K.K

OriCiro Genomics K.K Market Share Analysis for May 2026

Industry: N/A

Domainoriciro.com

Year Founded2018

Employees51 - 200

Annual Revenue$10M - $15M

OriCiro Genomics K.K

OriCiro Genomics K.K (including company regionals)

oriciro.com

See more website traffic and engagement information

OriCiro Genomics K.K Revenue up to May 2026 is 10M - 15M

revenue generated by OriCiro Genomics K.K top domains

OriCiro Genomics K.K top domains revenue over 3 years

Revenue for OriCiro Genomics K.K top domains

oriciro.com10M - 15M

See more with Sales Intelligence

Total visits to OriCiro Genomics K.K's top domains

Understand OriCiro Genomics K.K market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in OriCiro Genomics K.K's top domains

Analyze OriCiro Genomics K.K engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on OriCiro Genomics K.K's top domains

See how OriCiro Genomics K.K keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

OriCiro Genomics K.K top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by OriCiro Genomics K.K

These are the website technologies, by industry, used by OriCiro Genomics K.K top domains

Payment & Currencies (6)

Cart Functionality

Widget (3)

Twemoji

Advertising (2)

PubMatic

Content Management System (2)

WordPress

More Technologies

4

See all

News & Signals from OriCiro Genomics K.K

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOriciro launched OriCiro Cell-Free Switching system on Sep 1st '20.In November 2021, OriCiro Genomics Inc. launched the OriCiro Cell-Free Switching system.

NewsModerna acquires Oriciro for $85M.For $85 million, Moderna will purchase Japan-based OriCiro Genomics, which specializes in cell-free DNA synthesis and amplification technology.

NewsOriciro received financing of $7.3M in Series B on Jul 1st '21.Founded in 2018 to develop and commercialize a technology for cell-free assembly and amplification of large circular DNA, OriCiro raised approximately $7.3 million in Series B funding in July 2021, led by University of Tokyo Edge Capital Partners.